Aktienanalyse zu Koninklijke Philips NV (PHG)PHGKoninklijke Philips NV

Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others. It operates in the Healthcare sector.

Given the current price of $26.72 and a low RSI of 33.39 indicating oversold conditions, Philips NV may be a candidate for a long-term hold rather than a buy. However, the recent insider selling trend of 30126.47% raises concerns about confidence in the stock's near-term prospects. The forward P/E ratio of 14.60 suggests potential value, but the overall market sentiment remains cautious due to recent downgrades by analysts.

1 analysts cover PHG: 1 rate it Buy, 0 Hold and 0 Sell.